On November 19th, 2022, The 13th China (Taizhou) International Medical Expo kicked off in CMC Conference and Exhibition Center, Taizhou, Jiangsu.
He Wei, vice chairman of Chinese People’s Political Consultative Conference and executive vice chairman of the Central Committee of Chinese Peasants and Workers Democratic Party, delivered a speech by video and announced the opening of the conference. Chen Jian’an, vice president of Jiangsu Branch of China Council for the Promotion of International Trade, delivered a speech by video.
This 3-day Expo, sponsored by China Chamber of International Commerce and China Association of Chinese Medicine, and undertaken by Taizhou Municipal People’s Government and Jiangsu Branch of China Council for the Promotion of International Trade, has received massive support from Chinese Medical Association, Chinese Pharmaceutical Association, China Quality Association for Pharmaceuticals, National Institutes for Food and Drug Control, China Institute of Veterinary Drugs Control, Jiangsu Provincial Development and Reform Commission, Science and Technology Department, Industry and Information Department, Human Resources and Social Welfare Department, Commerce Department, Health and Health Commission, Market Supervision Bureau, Food and Drug Administration and Chinese Medicine Administration.
During the Expo, it will hold policy seminars, industry summit forums, cutting-edge technology promotion and other activities to study the development trend of medical and health industry under COVID-19 pandemic, strengthen exchanges and cooperation with medical societies, pharmaceutical enterprises and scientific research institutions at home and abroad, seize new opportunities for industry development, accelerate the convergence of domestic and foreign medical innovation resources to China Medical City, and better help Taizhou’s high-quality development of health industry.
In recent years, the cluster effect of Taizhou Pharmaceutical High-tech Zone has become increasingly prominent. Over the past 10 years, it has attracted more than 4,300 high-level talents at home and abroad to join in innovation and entrepreneurship, and gathered more than 1,300 pharmaceutical enterprises at home and abroad. The “3+2” industrial system has been accelerated, and a new path of gathering high-end talents, introducing high-end achievements, settling in high-end enterprises and developing high-end industries has been explored in the development of biomedical industry. Facing the new situation and new mission, Taizhou takes this Expo as an opportunity to further gather innovative resources, expand the opening up, strengthen cooperation and exchanges, actively enlarge the development advantages of industrial clusters, enhance key core technologies, deepen the deep integration of Industry-University-Research, and provide strong support for promoting the high-quality development of the biomedical industry in the whole province.
On November 19th, 2022, the launching ceremony of the construction of national biomedical clusters in Taizhou, Lianyungang and Wuxi was also held. In the future, Taizhou, Lianyungang and Wuxi will adhere to the same direction, co-construction and sharing, make progress towards the goal of cultivating world-class pharmaceutical clusters, and strive to become a global biomedical R&D and manufacturing cluster, the core bearing area of world-class biomedical clusters in the Yangtze River Delta, and the first demonstration area of national advanced manufacturing cluster governance mechanism.